XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 38 filers reported holding XENON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $495,000 | -20.2% | 101,103 | -53.9% | 0.03% | -37.8% |
| Q4 2017 | $620,000 | +27.8% | 219,543 | +33.5% | 0.04% | +40.6% |
| Q3 2017 | $485,000 | -6.4% | 164,510 | 0.0% | 0.03% | -5.9% |
| Q2 2017 | $518,000 | +10.7% | 164,510 | +40.6% | 0.03% | -12.8% |
| Q1 2017 | $468,000 | +6.1% | 116,975 | +104.4% | 0.04% | -7.1% |
| Q4 2016 | $441,000 | -97.1% | 57,228 | +278.4% | 0.04% | 0.0% |
| Q3 2016 | $15,122,000 | – | 15,122 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,516,851 | $44,101,000 | 2.72% |
| Parkman Healthcare Partners LLC | 590,267 | $7,402,000 | 2.08% |
| ACUTA CAPITAL PARTNERS, LLC | 517,500 | $6,489,000 | 1.88% |
| Soleus Capital Management, L.P. | 250,897 | $3,146,000 | 1.79% |
| DAFNA Capital Management LLC | 346,535 | $4,346,000 | 1.25% |
| KNOTT DAVID M | 169,000 | $2,119,000 | 1.16% |
| Ghost Tree Capital, LLC | 325,000 | $4,076,000 | 1.08% |
| Avoro Capital Advisors LLC | 2,800,000 | $35,112,000 | 0.69% |
| NEA Management Company, LLC | 992,107 | $12,441,000 | 0.50% |
| Orbimed Advisors | 2,497,917 | $31,324,000 | 0.44% |